Afc-HD AMS Life Science Co., Ltd. (2927) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Afc-HD AMS Life Science Co., Ltd. (2927:JPX), powered by AI.

Current Price
¥883
Sector
Consumer Defensive
What is the Afc-HD AMS Life Science Co., Ltd. stock price forecast?

Afc-HD AMS Life Science Co., Ltd. is currently trading at ¥883. View real-time AI analysis on Alpha Lenz.

What is Afc-HD AMS Life Science Co., Ltd. insider trading activity?

View the latest insider trading data for Afc-HD AMS Life Science Co., Ltd. on Alpha Lenz.

What is Afc-HD AMS Life Science Co., Ltd.'s P/E ratio?

View Afc-HD AMS Life Science Co., Ltd.'s valuation metrics on Alpha Lenz.

Afc-HD AMS Life Science Co., Ltd.

JPX · 2927
¥883
Ask about Afc-HD AMS Life Science Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Afc-HD AMS Life Science Co., Ltd.'s ROE is 10.0%. Explore profitability and growth together.

Ask for details

Company Overview

Afc-HD AMS Life Science Co., Ltd. operates as a health and dietary supplement company in Japan. The company's primary function is the development, production, and marketing of a diverse array of nutraceutical and health-related products aimed at enhancing well-being. With a focus on quality and safety, Afc-HD AMS Life Science collaborates with academic institutions and leverages advanced technologies to innovate in the health science sector. It services a broad consumer base through direct sales, retail, and digital platforms, providing supplements that cater to various health needs such as immune support, beauty enhancement, and lifestyle diseases. As part of the broader healthcare and personal care industry, the company plays a significant role in promoting preventive health and wellness trends. Positioned in the dynamic and growing market of health supplements, it contributes to the increasing global emphasis on health maintenance and an active lifestyle.

SectorConsumer Defensive
IndustryPackaged Foods
Employees994

Company Statistics

FY 2025

Profile

N/AMarket Cap
¥32,655,022,000Revenue
0.00Shares Out
994Employees

Margins

34.49%Gross
12.13%EBITDA
7.38%Operating
6.74%Pre-Tax
4.50%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

12.35%Rev 3Yr
15.60%Rev 5Yr
33.40%Op Inc 3Yr
17.11%Op Inc 5Yr
25.81%Net Inc 3Yr
16.77%Net Inc 5Yr

Returns

3.07%ROA
9.99%ROE
5.02%ROIC

Financial Health

¥11,303,492,000Cash & Cash Equivalents
¥22,223,025,000Net Debt
220.56%Debt/Equity
N/AInterest Cov
Alpha Chat Insight

Afc-HD AMS Life Science Co., Ltd.'s ROE is 10.0%. Explore profitability and growth together.

Ask for details

Frequently Asked Questions

Afc-HD AMS Life Science Co., Ltd. (ticker: 2927) is a company listed on JPX in the Consumer Defensive sector (Packaged Foods). It has approximately 994 employees.

The current price is 883 with a P/E ratio of -x and P/B of -x.

ROE is 9.99% and operating margin is 7.38%. Annual revenue is $32.7B.

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Afc-HD AMS Life Science Co., Ltd. (Consumer Defensive) Stock Forecast & Analysis ¥883 | Alpha Lenz